regadenoson has been researched along with Benign Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Borah, P; Deb, PK; Deka, S; Mailavaram, RP | 1 |
1 review(s) available for regadenoson and Benign Neoplasms
| Article | Year |
|---|---|
P1 Receptor Agonists/Antagonists in Clinical Trials - Potential Drug Candidates of the Future.
Topics: Adenosine; Asthma; Cardiovascular Diseases; Clinical Trials as Topic; Humans; Ligands; Neoplasms; Parkinson Disease; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Purines; Pyrazoles; Receptors, Purinergic P1 | 2019 |